Designing a Formulation of the Nootropic Drug Aniracetam Using 2-Hydroxypropyl-Β-Cyclodextrin Suitable for Parenteral Administration

Pharmaceutics - Switzerland
doi 10.3390/pharmaceutics10040240
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG


Related search